Skip to content

Prospective Genetic Study in Patients With Ovarian Insufficiency

Prospective Genetic Study in Patients With Ovarian Insufficiency

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03474120
Enrollment
300
Registered
2018-03-22
Start date
2018-04-20
Completion date
2023-12-24
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished Ovarian Reserve, Ovarian Dysgenesis, Premature Ovarian Failure, Primary Ovarian Insufficiency

Keywords

Genetic causes, etiology, POI, DOR

Brief summary

genetic screening and etiological analysis was conducted on patients with ovarian insufficiency and decline in ovarian reserve. All patients were enrolled in the IVF-treated and non-IVF-treated groups, followed up for long-term treatment outcomes and genomic screening.

Detailed description

The cause of ovarian insufficiency and decline in ovarian reserve are not clear, but most researchers think the probable causes are mainly three aspects: chromosomal abnormalities, genetic factors and autoimmune diseases,But the majority of patients with normal chromosome karyotype analysis. The screening of pathogenic genes in patients with normal karyotype is the focus of current premature ovarian insufficiency(POI) and decline in ovarian reserve(DOR) etiology, to further explain the pathogenesis of patients, improve the diagnosis of those diseases and Clinical treatment.

Interventions

PROCEDUREIVF treatment

Relationship between IVF treatment outcome and genotypes in POI//DOR/ovarian dysgenesis patients

Sponsors

National Research Institute for Family Planning, China
CollaboratorOTHER_GOV
The First Affiliated Hospital of Anhui Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed as premature ovarian insufficiency, diminished ovarian reserve, primary amenorrhea, ovarian dysgenesis, repeated implantation failure

Exclusion criteria

* To rule out polycystic ovary syndrome(PCOS), iatrogenic factors (such as surgery, radiotherapy and chemotherapy, etc.) lead to premature ovarian insufficiency in patients

Design outcomes

Primary

MeasureTime frameDescription
Genotype1/4/2018-24/12/2020Measure the genotype by genome-wide sequencing of exomes(WES) in subjects.

Secondary

MeasureTime frameDescription
Dimensions of uterus1/4/2018-24/12/2020Measure the vertical diameter,transverse diameter and anteroposterior diameter of uterus in millimeters
Antral follicle count1/4/2018-24/12/2020Measure the basic antral follicle count before controlled ovarian hyperstimulation.
Endometrial thickness1/4/2018-24/12/2020Measure endometrial thickness of subjects in millimeters.
Live birth rate1/4/2018-24/12/2020Record the live birth rate of offspring in in both groups.
Neonatal weight1/4/2018-24/12/2020Record the neonatal weight(in kilogram) of offspring in two groups.

Countries

China

Contacts

Primary ContactYiran Zhou, bachelor
zhouyiran0309@163.com+86 13605690313
Backup ContactBinbin Wang, PhD
wbbahu@163.com+86 13552883407

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026